相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting the tumor microenvironment as a potential therapeutic approach in colorectal cancer: Rational and progress
Afsane Bahrami et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Overall Survival in Patients With Advanced Melanoma Who Received Nivolumab Versus Investigator's Choice Chemotherapy in CheckMate 037: A Randomized, Controlled, Open-Label Phase III Trial
James Larkin et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
Gary E. Raskob et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Vemurafenib in metastatic melanoma patients with brain metastases: an open-label, single-arm, phase 2, multicentre study
G. A. McArthur et al.
ANNALS OF ONCOLOGY (2017)
Histopathologic diagnosis of brain metastases: current trends in management and future considerations
Lien Bekaert et al.
BRAIN TUMOR PATHOLOGY (2017)
Veliparib in combination with whole-brain radiation therapy for patients with brain metastases from non-small cell lung cancer: results of a randomized, global, placebo-controlled study
Pierre Chabot et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
Comparing pre-operative stereotactic radiosurgery (SRS) to postoperative whole brain radiation therapy (WBRT) for resectable brain metastases: a multi-institutional analysis
Kirtesh R. Patel et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
Dynamic O-(2-18F-fluoroethyl)-L-tyrosine positron emission tomography differentiates brain metastasis recurrence from radiation injury after radiotherapy
Garry Ceccon et al.
NEURO-ONCOLOGY (2017)
The efficacy of lapatinib and capecitabine in HER-2 positive breast cancer with brain metastases: A systematic review and pooled analysis
Fausto Petrelli et al.
EUROPEAN JOURNAL OF CANCER (2017)
Efficacy of the combination of ipilimumab and nivolumab following progression on pembrolizumab in advanced melanoma with poor risk features
Lavinia Spain et al.
EUROPEAN JOURNAL OF CANCER (2017)
Afatinib Therapy for Brain Metastases Aggravated by a Reduction in the Dose of Erlotinib Due to the Development of Hepatotoxicity
Yumie Yamanaka et al.
INTERNAL MEDICINE (2017)
Stereotactic Radiosurgery With or Without Whole-Brain Radiation Therapy for Limited Brain Metastases: A Secondary Analysis of the North Central Cancer Treatment Group N0574 (Alliance) Randomized Controlled Trial
Thomas M. Churilla et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA)
Paul W. Sperduto et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Osimertinib in Pretreated T790M-Positive Advanced Non-Small-Cell Lung Cancer: AURA Study Phase II Extension Component
James Chih-Hsin Yang et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial
Dong-Wan Kim et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Applications of DNA-Based Liquid Biopsy for Central Nervous System Neoplasms
Joanna Wang et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2017)
Anticoagulation for the treatment of venous thromboembolism in patients with brain metastases: a meta-analysis and systematic review
Bradley D. Hunter et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2017)
First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study
Jean-Charles Soria et al.
LANCET (2017)
Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006)
Jacob Schachter et al.
LANCET (2017)
Alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial
Toyoaki Hida et al.
LANCET (2017)
Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC.3): a multicentre, randomised, controlled, phase 3 trial
Paul D. Brown et al.
LANCET ONCOLOGY (2017)
Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial
Alice T. Shaw et al.
LANCET ONCOLOGY (2017)
Treatment options for EGFR mutant NSCLC with CNS involvement-Can patients BLOOM with the use of next generation EGFR TKIs?
Chee-Seng Tan et al.
LUNG CANCER (2017)
Paradigm shift of therapeutic management of brain metastases in EGFR-mutant non-small cell lung cancer in the era of targeted therapy
Akimasa Sekine et al.
MEDICAL ONCOLOGY (2017)
Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO)
Riccardo Soffietti et al.
NEURO-ONCOLOGY (2017)
Cerebrospinal fluid circulating tumor cells: a novel tool to diagnose leptomeningeal metastases from epithelial tumors
Xuling Lin et al.
NEURO-ONCOLOGY (2017)
Three or More Courses of Stereotactic Radiosurgery for Patients with Multiply Recurrent Brain Metastases
Rupesh Kotecha et al.
NEUROSURGERY (2017)
Treatment of brain metastases in the modern genomic era
Ibiayi Dagogo-Jack et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Stereotactic radiosurgery versus whole-brain radiotherapy after intracranial metastasis resection: a systematic review and meta-analysis
Nayan Lamba et al.
RADIATION ONCOLOGY (2017)
Icotinib versus whole-brain irradiation in patients with EGFR-mutant non-small-cell lung cancer and multiple brain metastases (BRAIN): a multicentre, phase 3, open-label, parallel, randomised controlled trial
Jin-Ji Yang et al.
LANCET RESPIRATORY MEDICINE (2017)
Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial
Rafael Rosell et al.
LANCET RESPIRATORY MEDICINE (2017)
Estimating Survival in Patients With Lung Cancer and Brain Metastases An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)
Paul W. Sperduto et al.
JAMA ONCOLOGY (2017)
Concurrent Afatinib and Whole-Brain Radiotherapy in Exon 19-del-EGFR Mutant Lung Adenocarcinoma: A Case Report and Mini Review of the Literature
Chukwuka Eze et al.
FRONTIERS IN ONCOLOGY (2017)
Discordance and Conversion Rates of Progesterone-, Estrogen-, and HER2/neu-Receptor Status in Primary Breast Cancer and Brain Metastasis Mainly Triggered by Hormone Therapy
Marco Timmer et al.
ANTICANCER RESEARCH (2017)
The role of the neural niche in brain metastasis
Reid Hoshide et al.
CLINICAL & EXPERIMENTAL METASTASIS (2017)
First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advanced EGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open-label, randomized study
Y. K. Shi et al.
ANNALS OF ONCOLOGY (2017)
Ipilimumab and Stereotactic Radiosurgery Versus Stereotactic Radiosurgery Alone for Newly Diagnosed Melanoma Brain Metastases
Kirtesh R. Patel et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2017)
Complete remission of intrathecal metastases with lorlatinib therapy in a heavily pretreated ALK-positive lung cancer patient
Maximilian J. Hochmair et al.
ANTI-CANCER DRUGS (2017)
PET scan and NMR spectroscopy for the differential diagnosis between brain radiation necrosis and tumour recurrence after stereotactic irradiation of brain metastases: Place in the decision tree
I. Menoux et al.
CANCER RADIOTHERAPIE (2017)
Novel therapeutic agents in the management of brain metastases
Vyshak A. Venur et al.
CURRENT OPINION IN ONCOLOGY (2017)
Brain metastasization of breast cancer
Tania Custodio-Santos et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2017)
EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours
E. Le Rhun et al.
ANNALS OF ONCOLOGY (2017)
Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study
G. V. Long et al.
ANNALS OF ONCOLOGY (2017)
Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases
Sagun Parakh et al.
BRITISH JOURNAL OF CANCER (2017)
Is primary prevention with antiepileptic drugs effective in brain tumors or brain metastases?
Diego Lobos-Urbina et al.
MEDWAVE (2017)
Targeted Treatment of Brain Metastases
Nicole Shonka et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2017)
Hippocampal-Sparing Whole-Brain Radiotherapy for Lung Cancer
Ren Zhao et al.
CLINICAL LUNG CANCER (2017)
MET receptor inhibition: Hope against resistance to targeted therapies?
Audrey Hochart et al.
BULLETIN DU CANCER (2017)
BRAF-Mutated Colorectal Cancer: What Is the Optimal Strategy for Treatment?
Romain Cohen et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2017)
Molecular Testing for Gastrointestinal Cancer
Hye Seung Lee et al.
JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE (2017)
Clinical outcomes of melanoma brain metastases treated with stereotactic radiation and anti-PD-1 therapy
K. A. Ahmed et al.
ANNALS OF ONCOLOGY (2016)
Screening, resilience, patient navigation and information needs - key areas in cancer control
D. Weller
EUROPEAN JOURNAL OF CANCER CARE (2016)
Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy
Zeynep Eroglu et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2016)
Risk factors for brain metastasis as a first site of disease recurrence in patients with HER2 positive early stage breast cancer treated with adjuvant trastuzumab
Onder Tonyali et al.
BREAST (2016)
Timing and Type of Immune Checkpoint Therapy Affect the Early Radiographic Response of Melanoma Brain Metastases to Stereotactic Radiosurgery
Jack M. Qian et al.
CANCER (2016)
Imaging methods used in the differential diagnosis between brain tumour relapse and radiation necrosis after stereotactic radiosurgery of brain metastases: Literature review
I. Menoux et al.
CANCER RADIOTHERAPIE (2016)
Ipilimumab Combined with Nivolumab: A Standard of Care for the Treatment of Advanced Melanoma?
Matteo S. Carlino et al.
CLINICAL CANCER RESEARCH (2016)
Preclinical Comparison of Osimertinib with Other EGFR-TKIs in EGFR-Mutant NSCLC Brain Metastases Models, and Early Evidence of Clinical Brain Metastases Activity
Peter Ballard et al.
CLINICAL CANCER RESEARCH (2016)
Metastatic melanoma treatment: Combining old and new therapies
Ryan J. Davey et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
Treatment of brain metastasis: current status and future directions
Roberta Ruda et al.
CURRENT OPINION IN ONCOLOGY (2016)
Imaging and Clinical Profile Following Concurrent Stereotactic Radiation and Immune Therapy for Melanoma Brain Metastases: Preliminary Results
C. Shen et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Surgical Resection of Brain Metastases and the Risk of Leptomeningeal Recurrence in Patients Treated With Stereotactic Radiosurgery
Matthew D. Johnson et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Single-Fraction Versus Multifraction (3 x 9 Gy) Stereotactic Radiosurgery for Large ( > 2 cm) Brain Metastases: A Comparative Analysis of Local Control and Risk of Radiation-Induced Brain Necrosis
Giuseppe Minniti et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases A Randomized Clinical Trial
Paul D. Brown et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Evaluating Cancer of the Central Nervous System Through Next-Generation Sequencing of Cerebrospinal Fluid
Elena I. Pentsova et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Translational Breast Cancer Research Consortium (TBCRC) 022: A Phase II Trial of Neratinib for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases
Rachel A. Freedman et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Multicenter Phase II Study of Whole-Body and Intracranial Activity With Ceritinib in Patients With ALK-Rearranged Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy and Crizotinib: Results From ASCEND-2
Lucio Crino et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Response of symptomatic brain metastases from HER-2 overexpressing breast cancer with T-DM1
C. L. Gorter de Vries et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Nivolumab (nivo) in Patients (pts) With Advanced (adv) NSCLC and Central Nervous System (CNS) Metastases (mets)
Jonathan W. Goldman et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
First-Line Afatinib versus Chemotherapy in Patients with Non-Small Cell Lung Cancer and Common Epidermal Growth Factor Receptor Gene Mutations and Brain Metastases
Martin Schuler et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial
Paula Mulvenna et al.
LANCET (2016)
Activity and safety of brigatinib in ALK-rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trial
Scott N. Gettinger et al.
LANCET ONCOLOGY (2016)
Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial
Sarah B. Goldberg et al.
LANCET ONCOLOGY (2016)
Dabrafenib plus trametinib in patients with previously treated BRAFV600E-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial
David Planchard et al.
LANCET ONCOLOGY (2016)
Intracranial response to nivolumab in NSCLC patients with untreated or progressing CNS metastases
Elizabeth Dudnik et al.
LUNG CANCER (2016)
Updates in the management of brain metastases
Nils D. Arvold et al.
NEURO-ONCOLOGY (2016)
215 Postoperative Stereotactic Radiosurgery vs Observation for Completely Resected Brain Metastases
Ganesh Rao et al.
NEUROSURGERY (2016)
AZD3759, a BBB-penetrating EGFR inhibitor for the treatment of EGFR mutant NSCLC with CNS metastases
Zhenfan Yang et al.
Science Translational Medicine (2016)
New Therapeutic Opportunities Based on DNA Mismatch Repair and BRAF Status in Metastatic Colorectal Cancer
Romain Cohen et al.
CURRENT ONCOLOGY REPORTS (2016)
Local Tumor Treatment in Combination with Systemic Ipilimumab Immunotherapy Prolongs Overall Survival in Patients with Advanced Malignant Melanoma
Sebastian Theurich et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Radiotherapy plus EGFR TKIs in non-small cell lung cancer patients with brain metastases: an update meta-analysis
Tao Jiang et al.
CANCER MEDICINE (2016)
Embracing rejection: Immunologic trends in brain metastasis
S. Harrison Farber et al.
ONCOIMMUNOLOGY (2016)
Usefulness of quantitative peritumoural perfusion and proton spectroscopic magnetic resonance imaging evaluation in differentiating brain gliomas from solitary brain metastases
Gianvincenzo Sparacia et al.
NEURORADIOLOGY JOURNAL (2016)
Radiosurgery to the Postoperative Tumor Bed for Metastatic Carcinoma Versus Whole Brain Radiation After Surgery
Kristen Scheitler-Ring et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2016)
Balancing bleeding in brain metastases
Lisa Baumann Kreuziger
BLOOD (2015)
Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer
Jin Sun Lee et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Activity of T-DM1 in Her2-positive breast cancer brain metastases
Rupert Bartsch et al.
CLINICAL & EXPERIMENTAL METASTASIS (2015)
Bevacizumab Preconditioning Followed by Etoposide and Cisplatin Is Highly Effective in Treating Brain Metastases of Breast Cancer Progressing from Whole-Brain Radiotherapy
Yen-Shen Lu et al.
CLINICAL CANCER RESEARCH (2015)
Diagnostic imaging of intracranial metastasis
Stephen F. Kralik et al.
CURRENT PROBLEMS IN CANCER (2015)
Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab: A meta-analysis
Filippo Pietrantonio et al.
EUROPEAN JOURNAL OF CANCER (2015)
Differentiation of high-grade-astrocytomas from solitary-brain-metastases: Comparing diffusion kurtosis imaging and diffusion tensor imaging
Yan Tan et al.
EUROPEAN JOURNAL OF RADIOLOGY (2015)
Testing for oncogenic molecular aberrations in cell-free DNA-based liquid biopsies in the clinic: are we there yet?
Jiri Polivka et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2015)
Repeat Courses of Stereotactic Radiosurgery (SRS), Deferring Whole-Brain Irradiation, for New Brain Metastases After Initial SRS
David B. Shultz et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Competing Risk Analysis of Neurologic versus Nonneurologic Death in Patients Undergoing Radiosurgical Salvage After Whole-Brain Radiation Therapy Failure: Who Actually Dies of Their Brain Metastases?
John T. Lucas et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Phase 3 Trials of Stereotactic Radiosurgery With or Without Whole-Brain Radiation Therapy for 1 to 4 Brain Metastases: Individual Patient Data Meta-Analysis
Arjun Sahgal et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Stereotactic Radiosurgery for Melanoma Brain Metastases in Patients Receiving Ipilimumab: Safety Profile and Efficacy of Combined Treatment
Ana P. Kiess et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Leukoencephalopathy After Stereotactic Radiosurgery for Brain Metastases
Daniel M. Trifiletti et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Clinical Experience With Crizotinib in Patients With Advanced ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastases
Daniel B. Costa et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Donepezil for Irradiated Brain Tumor Survivors: A Phase III Randomized Placebo-Controlled Clinical Trial
Stephen R. Rapp et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
NCCTG N0574 (Alliance): A phase III randomized trial of whole brain radiation therapy (WBRT) in addition to radiosurgery (SRS) in patients with 1 to 3 brain metastases
Paul D. Brown et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
Gary H. Lyman et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
Dirk Schadendorf et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Do Circulating Tumor Cells, Exosomes, and Circulating Tumor Nucleic Acids Have Clinical Utility? A Report of the Association for Molecular Pathology
Bert Gold et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2015)
The brain metastatic niche
Frank Winkler
JOURNAL OF MOLECULAR MEDICINE-JMM (2015)
Hypofractionated radiosurgery has a better safety profile than single fraction radiosurgery for large resected brain metastases
Bree R. Eaton et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Veliparib in combination with whole brain radiation therapy in patients with brain metastases: results of a phase 1 study
Minesh P. Mehta et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases
Zachary A. Kohutek et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Impact of surgical methodology on the complication rate and functional outcome of patients with a single brain metastasis
Akash J. Patel et al.
JOURNAL OF NEUROSURGERY (2015)
Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significance
Jodi M. Saunus et al.
JOURNAL OF PATHOLOGY (2015)
Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial
Georgina V. Long et al.
LANCET (2015)
Afatinib alone or afatinib plus vinorelbine versus investigator's choice of treatment for HER2-positive breast cancer with progressive brain metastases after trastuzumab, lapatinib, or both (LUX-Breast 3): a randomised, open-label, multicentre, phase 2 trial
Javier Cortes et al.
LANCET ONCOLOGY (2015)
Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials
James Chih-Hsin Yang et al.
LANCET ONCOLOGY (2015)
Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial
Jeffrey S. Weber et al.
LANCET ONCOLOGY (2015)
Tumor Progression in Patients Receiving Adjuvant Whole-Brain Radiotherapy vs Localized Radiotherapy After Surgical Resection of Brain Metastases
Jason Hsieh et al.
NEUROSURGERY (2015)
Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nivolumab in Previously Untreated Melanoma without BRAF Mutation
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer
Julie Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer
Sandra M. Swain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
A Retrospective Evaluation of Vemurafenib as Treatment for BRAF-Mutant Melanoma Brain Metastases
James J. Harding et al.
ONCOLOGIST (2015)
Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma
Leticia De Mattos-Arruda et al.
NATURE COMMUNICATIONS (2015)
Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets
Priscilla K. Brastianos et al.
CANCER DISCOVERY (2015)
Next-Generation Sequencing of Stage IV Squamous Cell Lung Cancers Reveals an Association of PI3K Aberrations and Evidence of Clonal Heterogeneity in Patients with Brain Metastases
Paul K. Paik et al.
CANCER DISCOVERY (2015)
Stereotactic Radiosurgery With or Without Whole-Brain Radiotherapy for Brain Metastases Secondary Analysis of the JROSG 99-1 Randomized Clinical Trial
Hidefumi Aoyama et al.
JAMA ONCOLOGY (2015)
Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study
A. M. Di Giacomo et al.
ANNALS OF ONCOLOGY (2015)
Extended RAS mutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized, controlled trials
M. J. Sorich et al.
ANNALS OF ONCOLOGY (2015)
LINAC-based stereotactic radiosurgery to the brain with concurrent vemurafenib for melanoma metastases
Kamran A. Ahmed et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Breast cancer brain metastases: the last frontier
Jose Pablo Leone et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2015)
Prognostic scores for brain metastasis patients: use in clinical practice and trial design
Vyshak Alva Venur et al.
CHINESE CLINICAL ONCOLOGY (2015)
Systemic therapies for melanoma brain metastases: which drug for whom and when?
Sangeetha Ramanujam et al.
CHINESE CLINICAL ONCOLOGY (2015)
Strategies for preservation of memory function in patients with brain metastases
Nicholas B. Dye et al.
CHINESE CLINICAL ONCOLOGY (2015)
Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results from the randomized phase III study CLEOPATRA
S. M. Swain et al.
ANNALS OF ONCOLOGY (2014)
Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2
M. Piccart et al.
ANNALS OF ONCOLOGY (2014)
Role of the Neural Niche in Brain Metastatic Cancer
John Termini et al.
CANCER RESEARCH (2014)
A systematic review of dual targeting in HER2-positive breast cancer
Iben Kumler et al.
CANCER TREATMENT REVIEWS (2014)
Indications and limitations of chemotherapy and targeted agents in non-small cell lung cancer brain metastases
Stefan Zimmermann et al.
CANCER TREATMENT REVIEWS (2014)
Can diffusion-weighted imaging be used to differentiate brain abscess from other ring-enhancing brain lesions? A meta-analysis
X. -X. Xu et al.
CLINICAL RADIOLOGY (2014)
Targeting the MET gene for the treatment of non-small-cell lung cancer
F. Gelsomino et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2014)
BRAF alterations in brain tumours: molecular pathology and therapeutic opportunities
Anna Sophie Berghoff et al.
CURRENT OPINION IN NEUROLOGY (2014)
Targeted Therapies in Brain Metastases
Nancy U. Lin
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2014)
Vemurafenib in patients with BRAFV600 mutation-positive melanoma with symptomatic brain metastases: Final results of an open-label pilot study
Reinhard Dummer et al.
EUROPEAN JOURNAL OF CANCER (2014)
Napsin A is a useful marker for metastatic adenocarcinomas of pulmonary origin
Moon-Young Kim et al.
HISTOPATHOLOGY (2014)
Molecular Biology of Brain Metastasis
Konstantina A. Svokos et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Salvage Radiosurgery for Brain Metastases: Prognostic Factors to Consider in Patient Selection
Goldie Kurtz et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Hippocampal-Avoidance Whole-Brain Radiation Therapy: A New Standard for Patients With Brain Metastases?
John H. Suh
JOURNAL OF CLINICAL ONCOLOGY (2014)
Preservation of Memory With Conformal Avoidance of the Hippocampal Neural Stem-Cell Compartment During Whole-Brain Radiotherapy for Brain Metastases (RTOG 0933): A Phase II Multi-Institutional Trial
Vinai Gondi et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Sensitive Detection of EGFR Mutations in Cerebrospinal Fluid from Lung Adenocarcinoma Patients with Brain Metastases
Haihong Yang et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2014)
Intracranial control and radiographic changes with adjuvant radiation therapy for resected brain metastases: whole brain radiotherapy versus stereotactic radiosurgery alone
Kirtesh R. Patel et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Fractionated stereotactic radiosurgery for patients with brain metastases
Giuseppe Minniti et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Randomized Trial of Erlotinib Plus Whole-Brain Radiotherapy for NSCLC Patients With Multiple Brain Metastases
Siow Ming Lee et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Discoidin Domain Receptor 2 Signaling Networks and Therapy in Lung Cancer
Leo S. Payne et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK-rearranged non-small-cell lung cancer (AF-002JG): results from the dose-finding portion of a phase 1/2 study
Shirish M. Gadgeel et al.
LANCET ONCOLOGY (2014)
High rate of FGFR1 amplifications in brain metastases of squamous and non-squamous lung cancer
Matthias Preusser et al.
LUNG CANCER (2014)
Role of the endothelin axis in astrocyte- and endothelial cell-mediated chemoprotection of cancer cells
Seung Wook Kim et al.
NEURO-ONCOLOGY (2014)
Ceritinib in ALK-Rearranged Non-Small-Cell Lung Cancer REPLY
Alice T. Shaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Combined Vemurafenib and Cobimetinib in BRAF-Mutated Melanoma
James Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
The Value of Diffusion Tensor Imaging in Differentiating High-Grade Gliomas from Brain Metastases: A Systematic Review and Meta-Analysis
Rui Jiang et al.
PLOS ONE (2014)
Human breast cancer metastases to the brain display GABAergic properties in the neural niche
Josh Neman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
EGFR-TKI therapy for patients with brain metastases from non-small-cell lung cancer: a pooled analysis of published data
Yun Fan et al.
ONCOTARGETS AND THERAPY (2014)
In Search of the Ideal Immunopanel to Distinguish Metastatic Mammary Carcinoma From Primary Lung Carcinoma: A Tissue Microarray Study of 207 Cases
Kathy R. Kawaguchi et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2014)
Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis
Eric Ojerholm et al.
JOURNAL OF NEUROSURGERY (2014)
Genome-wide copy number analysis of cerebrospinal fluid tumor cells and their corresponding archival primary tumors
Mark Jesus M. Magbanua et al.
GENOMICS DATA (2014)
Ceritinib in ALK-Rearranged Non-Small-Cell Lung Cancer
Alice T. Shaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Temozolomide for treatment of brain metastases: A review of 21 clinical trials
Wei Zhu et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2014)
Leukoencephalopathy after whole-brain radiation therapy plus radiosurgery versus radiosurgery alone for metastatic lung cancer
Edward A. Monaco et al.
CANCER (2013)
Molecular Profiling of Tumor Cells in Cerebrospinal Fluid and Matched Primary Tumors from Metastatic Breast Cancer Patients with Leptomeningeal Carcinomatosis
Mark Jesus M. Magbanua et al.
CANCER RESEARCH (2013)
A systematic review of trastuzumab and lapatinib in the treatment of women with brain metastases from HER2-positive breast cancer
Pia Bukmann Larsen et al.
CANCER TREATMENT REVIEWS (2013)
Cerebrospinal Fluid Concentrations of Gefitinib in Patients With Lung Adenocarcinoma
Jing Zhao et al.
CLINICAL LUNG CANCER (2013)
A Phase 3 Trial of Whole Brain Radiation Therapy and Stereotactic Radiosurgery Alone Versus WBRT and SRS With Temozolomide or Erlotinib for Non-Small Cell Lung Cancer and 1 to 3 Brain Metastases: Radiation Therapy Oncology Group 0320
Paul W. Sperduto et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
The Abscopal Effect Associated With a Systemic Anti-melanoma Immune Response
Emily F. Stamell et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Risk of Leptomeningeal Disease in Patients Treated With Stereotactic Radiosurgery Targeting the Postoperative Resection Cavity for Brain Metastases
Banu Atalar et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Brain metastases as the first symptom of lung cancer: a clinical study from an Asian medical center
Jia Jin et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
A European Organisation for Research and Treatment of Cancer Phase III Trial of Adjuvant Whole-Brain Radiotherapy Versus Observation in Patients With One to Three Brain Metastases From Solid Tumors After Surgical Resection or Radiosurgery: Quality-of-Life Results
Riccardo Soffietti et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Phase II Trial of Erlotinib Plus Concurrent Whole-Brain Radiation Therapy for Patients With Brain Metastases From Non-Small-Cell Lung Cancer
James W. Welsh et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
EGFR mutation status in brain metastases of non-small cell lung carcinoma
Fanny Burel-Vandenbos et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Clinical outcomes of patients treated with a second course of stereotactic radiosurgery for locally or regionally recurrent brain metastases after prior stereotactic radiosurgery
Daniel H. Kim et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Vemurafenib and radiation therapy in melanoma brain metastases
Ashwatha Narayana et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Diagnostic Performance of 18F-FET PET in Newly Diagnosed Cerebral Lesions Suggestive of Glioma
Marion Rapp et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
David Neal Franz et al.
LANCET (2013)
Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study
Thomas Bachelot et al.
LANCET ONCOLOGY (2013)
CNS metastases in non-small-cell lung cancer: Current role of EGFR-TKI therapy and future perspectives
Lars Arne Berger et al.
LUNG CANCER (2013)
ALK gene translocations and amplifications in brain metastases of non-small cell lung cancer
Matthias Preusser et al.
LUNG CANCER (2013)
Bevacizumab as a treatment for radiation necrosis of brain metastases post stereotactic radiosurgery
Dustin Boothe et al.
NEURO-ONCOLOGY (2013)
Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial
Paul D. Brown et al.
NEURO-ONCOLOGY (2013)
Ipilimumab in melanoma with limited brain metastases treated with stereotactic radiosurgery
Maya Mathew et al.
MELANOMA RESEARCH (2013)
Safety and Tumor Responses with Lambrolizumab (Anti-PD-1) in Melanoma
Omid Hamid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Population-based outcomes of boost versus salvage radiosurgery for brain metastases after whole brain radiotherapy
Fred Hsu et al.
RADIOTHERAPY AND ONCOLOGY (2013)
Concurrent Radiotherapy and Ipilimumab Immunotherapy for Patients with Melanoma
Christopher A. Barker et al.
CANCER IMMUNOLOGY RESEARCH (2013)
Ipilimumab and radiation therapy for melanoma brain metastases
Ann W. Silk et al.
CANCER MEDICINE (2013)
Brain metastases epidemiology and biology
Emeline Tabouret et al.
BULLETIN DU CANCER (2013)
Antiepileptic drugs as prophylaxis for post-craniotomy seizures
Jennifer Pulman et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)
Brain metastases: pathobiology and emerging targeted therapies
Matthias Preusser et al.
ACTA NEUROPATHOLOGICA (2012)
A meta-analysis evaluating stereotactic radiosurgery, whole-brain radiotherapy, or both for patients presenting with a limited number of brain metastases
May Tsao et al.
CANCER (2012)
Expression of antigen processing and presenting molecules in brain metastasis of breast cancer
Yan Liu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Therapeutic Implications of KIT in Melanoma
Michael A. Postow et al.
CANCER JOURNAL (2012)
Tissue confirmation of disease recurrence in breast cancer patients: Pooled analysis of multi-centre, multi-disciplinary prospective studies
Eitan Amir et al.
CANCER TREATMENT REVIEWS (2012)
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in the Treatment of Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Metastatic to the Brain
Mariam Jamal-Hanjani et al.
CLINICAL CANCER RESEARCH (2012)
Brain metastasis: opportunity for drug development?
Matthias Preusser et al.
CURRENT OPINION IN NEUROLOGY (2012)
Effect of cancer therapy on neural stem cells: implications for cognitive function
Erin Gibson et al.
CURRENT OPINION IN ONCOLOGY (2012)
Targeted therapy in brain metastasis
Riccardo Soffietti et al.
CURRENT OPINION IN ONCOLOGY (2012)
Prognostic Factors for Survival in Patients Treated With Stereotactic Radiosurgery for Recurrent Brain Metastases After Prior Whole Brain Radiotherapy
Jorge A. Caballero et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers
Kristin Bergethon et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival Clinical article
Jonathan P. S. Knisely et al.
JOURNAL OF NEUROSURGERY (2012)
Combined Therapy with Mutant-Selective EGFR Inhibitor and Met Kinase Inhibitor for Overcoming Erlotinib Resistance in EGFR-Mutant Lung Cancer
Takayuki Nakagawa et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial
Kim Margolin et al.
LANCET ONCOLOGY (2012)
Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial
Georgina V. Long et al.
LANCET ONCOLOGY (2012)
Toward determining the lifetime occurrence of metastatic brain tumors estimated from 2007 United States cancer incidence data
Faith G. Davis et al.
NEURO-ONCOLOGY (2012)
Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
Keith T. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Iodine-125 brachytherapy for brain tumours - a review
Silke B. Schwarz et al.
RADIATION ONCOLOGY (2012)
From genes to drugs: targeted strategies for melanoma
Keith T. Flaherty et al.
NATURE REVIEWS CANCER (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Systematic Review: Anti-Epidermal Growth Factor Receptor Treatment Effect Modification by KRAS Mutations in Advanced Colorectal Cancer
Issa J. Dahabreh et al.
ANNALS OF INTERNAL MEDICINE (2011)
Prognostic Factors for Survival in Melanoma Patients With Brain Metastases
Michael A. Davies et al.
CANCER (2011)
Impact of BRAF Mutation and Microsatellite Instability on the Pattern of Metastatic Spread and Prognosis in Metastatic Colorectal Cancer
Ben Tran et al.
CANCER (2011)
Interaction between lung cancer cells and astrocytes via specific inflammatory cytokines in the microenvironment of brain metastasis
Toshihiro Seike et al.
CLINICAL & EXPERIMENTAL METASTASIS (2011)
Phase I Clinical Trial Outcomes in 93 Patients with Brain Metastases: The MD Anderson Cancer Center Experience
Apostolia Maria Tsimberidou et al.
CLINICAL CANCER RESEARCH (2011)
Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation
R. Porta et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
CSF Concentration of the Anaplastic Lymphoma Kinase Inhibitor Crizotinib
Daniel B. Costa et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study
Martin Kocher et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Stereotactic radiosurgery as primary and salvage treatment for brain metastases from breast cancer Clinical article
Douglas Kondziolka et al.
JOURNAL OF NEUROSURGERY (2011)
Safety and clinical activity of ipilimumab in melanoma patients with brain metastases: retrospective analysis of data from a phase 2 trial
Jeffrey S. Weber et al.
MELANOMA RESEARCH (2011)
The Molecular Pathobiology of Metastasis to the Brain: A Review
Kara D. Beasley et al.
NEUROSURGERY CLINICS OF NORTH AMERICA (2011)
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Leptomeningeal Metastasis: Challenges in Diagnosis and Treatment
Ticiana Leal et al.
CURRENT CANCER THERAPY REVIEWS (2011)
Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors
Andres Server et al.
ACTA RADIOLOGICA (2010)
Macrophage Diversity Enhances Tumor Progression and Metastasis
Bin-Zhi Qian et al.
CELL (2010)
Intracerebral metastasis showing restricted diffusion: Correlation with histopathologic findings
G. Duygulu et al.
EUROPEAN JOURNAL OF RADIOLOGY (2010)
Hallmarks of cancer: Interactions with the tumor stroma
Kristian Pietras et al.
EXPERIMENTAL CELL RESEARCH (2010)
INTRACRANIAL METASTATIC DISEASE SPARES THE LIMBIC CIRCUIT: A REVIEW OF 697 METASTATIC LESIONS IN 107 PATIENTS
James C. Marsh et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
DIAGNOSIS-SPECIFIC PROGNOSTIC FACTORS, INDEXES, AND TREATMENT OUTCOMES FOR PATIENTS WITH NEWLY DIAGNOSED BRAIN METASTASES: A MULTI-INSTITUTIONAL ANALYSIS OF 4,259 PATIENTS
Paul W. Sperduto et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Antiepileptics in brain metastases: safety, efficacy and impact on life expectancy
M. Maschio et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
The role of chemotherapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline
Minesh P. Mehta et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
The role of prophylactic anticonvulsants in the management of brain metastases: a systematic review and evidence-based clinical practice guideline
Tom Mikkelsen et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline
Timothy C. Ryken et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
EMT, the cytoskeleton, and cancer cell invasion
Mahmut Yilmaz et al.
CANCER AND METASTASIS REVIEWS (2009)
Mechanics, malignancy, and metastasis: The force journey of a tumor cell
Sanjay Kumar et al.
CANCER AND METASTASIS REVIEWS (2009)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
Whole brain radiotherapy plus stereotactic radiosurgery (WBRT plus SRS) versus surgery plus whole brain radiotherapy (OP plus WBRT) for 1-3 brain metastases: Results of a matched pair analysis
Dirk Rades et al.
EUROPEAN JOURNAL OF CANCER (2009)
MOTEXAFIN GADOLINIUM COMBINED WITH PROMPT WHOLE BRAIN RADIOTHERAPY PROLONGS TIME TO NEUROLOGIC PROGRESSION IN NON-SMALL-CELL LUNG CANCER PATIENTS WITH BRAIN METASTASES: RESULTS OF A PHASE III TRIAL
Minesh P. Mehta et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Stereotactic radiosurgery for metastatic brain tumors: a comprehensive review of complications Clinical article
Brian J. Williams et al.
JOURNAL OF NEUROSURGERY (2009)
Activation of MET by Gene Amplification or by Splice Mutations Deleting the Juxtamembrane Domain in Primary Resected Lung Cancers
Ryoichi Onozato et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial
Eric L. Chang et al.
LANCET ONCOLOGY (2009)
Salvage Stereotactic Radiosurgery Effectively Treats Recurrences From Whole-brain Radiation Therapy
Samuel T. Chao et al.
CANCER (2008)
Temozolomide, Thalidomide, and Whole Brain Radiation Therapy for Patients With Brain Metastasis From Metastatic Melanoma A Phase II Cytokine Working Group Study
Michael B. Atkins et al.
CANCER (2008)
Brain metastases: current management and new developments
Riccardo Soffietti et al.
CURRENT OPINION IN ONCOLOGY (2008)
A new prognostic index and comparison to three other indices for patients with brain metastases: An analysis of 1,960 patients in the RTOG database
Paul W. Sperduto et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Major response to imatinib mesylate in KIT-mutated melanoma
F. Stephen Hodi et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Phase II trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2-positive breast cancer
Nancy U. Lin et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Comparative risk of leptomeningeal disease after resection or stereotactic radiosurgery for solid tumor metastasis to the posterior fossa
Dima Suki et al.
JOURNAL OF NEUROSURGERY (2008)
Improved survival, quality of life, and quality-adjusted survival in breast cancer patients treated with efaproxiral (efaproxyn) plus whole-brain radiation therapy for brain Metastases
Charles Scott et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2007)
Distribution of brain metastases in relation to the hippocampus:: Implications for neurocognitive functional preservation
Amol Ghia et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Treatment of single brain metastasis with resection, intracavity carmustine polymer wafers, and radiation therapy is safe and provides excellent local control
Matthew G. Ewend et al.
CLINICAL CANCER RESEARCH (2007)
Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function
Jing Li et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Plasma and cerebrospinal fluid pharmacokinetics of erlotinib and its active metabolite OSI-420
Alberto Broniscer et al.
CLINICAL CANCER RESEARCH (2007)
Pitfalls in the diagnosis of brain tumours
Antonio M. P. Omuro et al.
LANCET NEUROLOGY (2006)
Immunohistochemical analysis of metastatic neoplasms of the central nervous system
Mark W. Becher et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma
Edgardo Rivera et al.
CANCER (2006)
Pathology-based substrate for target definition in radiosurgery of brain metastases
Brigitta G. Baumert et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases - A randomized controlled trial
Hidefumi Aoyama et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Brainstem metastases: Management using gamma knife radiosurgery
S Fuentes et al.
NEUROSURGERY (2006)
Phase II trial of radiosurgery for one to three newly diagnosed brain metastases from renal cell carcinoma, melanoma, and sarcoma: An eastern cooperative oncology group study (E 6397)
R Manon et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases
MP Mehta et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Resection of brain metastases previously treated with stereotactic radiosurgery
GG Vecil et al.
JOURNAL OF NEUROSURGERY (2005)
Treatment of brain metastases from lung cancer: chemotherapy
W Schuette
LUNG CANCER (2004)
Distinction between high-grade gliomas and solitary metastases using peritumoral 3-T magnetic resonance spectroscopy, diffusion, and perfusion imagings
IC Chiang et al.
NEURORADIOLOGY (2004)
Gefitinib in patients with brain metastases from non-small-cell lung cancer:: a prospective trial
GL Ceresoli et al.
ANNALS OF ONCOLOGY (2004)
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
DW Andrews et al.
LANCET (2004)
Hypofractionated stereotactic radiotherapy alone without whole-brain irradiation for patients with solitary and oligo brain metastasis using noninvasive fixation of the skull
HI Aoyama et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
A comparison of surgical resection and stereotactic radiosurgery in the treatment of solitary brain metastases
BP O'Neill et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
Radiation injury and neurogenesis
ML Monje et al.
CURRENT OPINION IN NEUROLOGY (2003)
Properly selected patients with multiple brain metastases may benefit from aggressive treatment of their intracranial disease
BE Pollock et al.
JOURNAL OF NEURO-ONCOLOGY (2003)
Detection of unknown primary tumours in patients with cerebral metastases using whole-body 18F-flouorodeoxyglucose positron emission tomography
B Klee et al.
EUROPEAN JOURNAL OF NEUROLOGY (2002)
Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET
JK Chung et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2002)
Brain metastases from unknown primary tumour -: A prospective study
R Rudà et al.
JOURNAL OF NEUROLOGY (2001)
Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: Final report of RTOG protocol 90-05
E Shaw et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2000)
分享论文
